What are the diagnostic criteria for Gilbert syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Gilbert Syndrome

Gilbert syndrome is diagnosed by finding mild unconjugated hyperbilirubinemia with unconjugated bilirubin comprising more than 70-80% of total bilirubin, normal liver enzymes, and absence of hemolysis or other liver disease. 1, 2

Diagnostic Criteria

  • Total bilirubin levels are typically mildly elevated, usually less than 4-5 mg/dL 1
  • Unconjugated (indirect) bilirubin should comprise more than 70-80% of total bilirubin (or conjugated bilirubin less than 20-30% of total) 1, 2
  • Normal liver enzymes and absence of hepatocellular disease 3
  • No evidence of hemolysis on complete blood count and other hemolytic markers 2, 4
  • Intermittent pattern of hyperbilirubinemia, often triggered by fasting, stress, or illness 3

Laboratory Evaluation Algorithm

Initial Testing

  • Complete liver function panel including:
    • Total bilirubin
    • Direct (conjugated) and indirect (unconjugated) bilirubin fractionation 2
    • AST, ALT, alkaline phosphatase, GGT 1
  • Complete blood count to rule out hemolysis 2
  • Calculate the proportion of conjugated bilirubin (should be <20-30% of total bilirubin) 1, 2

Rule Out Hemolysis

  • Reticulocyte count
  • Haptoglobin
  • Lactate dehydrogenase (LDH)
  • Peripheral blood smear 2, 4

Rule Out Other Liver Diseases

  • Viral hepatitis serologies
  • Autoimmune markers if clinically indicated 1, 2

Additional Diagnostic Tests

When Diagnosis Is Unclear

  • Breakdown of direct bilirubin fraction into conjugated and delta bilirubin 1, 2
  • Genetic testing for mutations in the uridine 5'-diphospho-glucuronyl-transferase (UGT1A1) gene, particularly the UGT1A1*28 polymorphism 1, 3
  • Abdominal ultrasound to rule out structural liver or biliary tract abnormalities 1, 2

Specialized Tests (Rarely Needed)

  • Caloric restriction test (fasting for 24-48 hours) - causes increased unconjugated bilirubin in Gilbert syndrome, but has low specificity 4, 5
  • Rifampin test - can help differentiate Gilbert syndrome from other causes of hyperbilirubinemia 5

Important Clinical Considerations

  • Gilbert syndrome affects 5-10% of the population 1
  • The condition is caused by reduced activity (20-30% of normal) of the enzyme uridine 5'-diphospho-glucuronyl-transferase 1
  • Liver biopsy is not necessary or recommended for diagnosis 4, 3
  • While bilirubin levels typically remain below 5 mg/dL, rare cases may present with levels above 6 mg/dL 6
  • The diagnosis is primarily one of exclusion, but the pattern of predominantly unconjugated hyperbilirubinemia (>90% of total bilirubin) is highly specific for Gilbert syndrome 7

Common Pitfalls to Avoid

  • Misdiagnosing Gilbert syndrome as drug-induced liver injury, particularly in clinical trials 1
  • Failing to recognize that Gilbert syndrome can coexist with and exacerbate other conditions like G6PD deficiency, thalassemia, or spherocytosis 3
  • Performing unnecessary invasive testing when laboratory findings are characteristic 4, 7
  • Overlooking that fasting and illness can temporarily increase bilirubin levels in affected individuals 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Evaluation of Gilbert Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gilbert syndrome.

European journal of pediatrics, 2012

Research

Two easy-to-perform diagnostic tests for Gilbert's syndrome.

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 2002

Research

Gilbert's syndrome: diagnosis by typical serum bilirubin pattern.

Clinica chimica acta; international journal of clinical chemistry, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.